On September 3, 2025, a professional training team from the Ministry of Health, Department of Food and Drug, conducted a Good Manufacturing Practice (GMP) training session for employees of Hong kong Biopharmaceutical Co., Ltd.

The training aimed to enhance participants’ understanding of fundamental GMP principles and regulatory requirements, which are crucial for ensuring the quality, safety, and compliance of pharmaceutical manufacturing processes.

The session covered key topics including:
1. Fundamental principles and regulatory requirements of GMP
2. Quality assurance and safety measures in pharmaceutical manufacturing
3. Procedures and guidelines for proper GMP implementation
The training was delivered through a combination of theoretical lectures and practical discussions, enabling employees to deepen their knowledge of GMP compliance and strengthen their operational practices.
This initiative is part of the Ministry of Health’s broader effort to support and elevate national pharmaceutical production standards in alignment with international regulations. It also reflects Hong Gong Biopharmaceutical Co., Ltd.’s strong commitment to continuously improving its quality management systems and ensuring readiness for future GMP inspections and certification processes.
Through this training, the company is further strengthening its capacity to deliver safe and high-quality pharmaceutical products to the public.